Mind Medicine Inc (MNMD) Stock: A Year of Declines and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Mind Medicine Inc’s current trading price is 3.70% away from its 52-week high, while its distance from the 52-week low is 377.61%. The stock’s price range for this period has been between $2.41 and $11.10 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.32 million for the day, a number notably higher than the average daily volume of 1.98 million over the last three months.

Mind Medicine Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $11.10 on 04/03/24 and a low of $2.41 for the same time frame on 11/13/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Mind Medicine Inc (MNMD) has experienced a quarterly rise of 217.97% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 324.14M and boasts a workforce of 57 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.93, with a change in price of +8.64. Similarly, Mind Medicine Inc recorded 1,498,537 in trading volume during the last 100 days, posting a change of +306.38%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MNMD stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.18.

MNMD Stock Stochastic Average

Mind Medicine Inc’s raw stochastic average for the past 50 days is presently 92.02%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 89.06%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 78.59% and 73.37%, respectively.

MNMD Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 214.49%. However, over the past six months, we’ve seen a weaker performance of 276.16%. The price of MNMD fallen by 84.46% over the last 30 days. And in the last five days, it has surged by 16.74%.

On Key

Related Posts